A recent research report published by Consilium Global Research predicts that ChineseInvestors.com (OTCQB: CIIX) will reach revenues of $14.8 million by fiscal year 2020 and that the company will undergo a major transformation this year as it pursues a bigger stake in the cannabis market. As cited in the report, ChineseInvestors.com achieved $930,000 in revenue … Continue reading “NetworkNewsBreaks – Consilium Global Research Report Projects ChineseInvestors.com, Inc. (CIIX) Will Reach $14.8M in Revenues by FY2020”
ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research (http://nnw.fm/kKO7e). Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through … Continue reading “ChineseInvestors.com, Inc. (CIIX) Projected To Reach Revenue of $14.8 Million by FY2020 in Consilium Global Research Report”
Leveraging its achievements of amassing a 100,000+ user base, establishing a recognizable 18-year-old brand, and sharpening its focus on a market that exceeds two billion Chinese-speaking individuals, ChineseInvestors.com (OTCQB: CIIX) has reached a first-in-the-marketplace milestone by launching the world’s first and only Chinese language, cannabinoid-based therapeutic health products web store, http://www.ChineseCBDoil.com. After making a successful … Continue reading “NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Pursues Continued Success in CBD Markets”
For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The … Continue reading “ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets”
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its appointment of Summer (XiangYang) Yun as chief executive officer of its CBD Biotechnology Co., Ltd. subsidiary, which it originally launched in March of this year. Yun brings over 25 years of marketing and branding experience to the CIIX team. As CEO of CBD Biotechnology, … Continue reading “NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Adds Summer Yun as CEO of CBD Biotechnology Co., Ltd.”
The chemical in marijuana that causes euphoria is delta-9 tetrahydrocannabinol, or THC. There are also over 100 other cannabinoid chemicals in the plant, including cannabidiol (CBD), one of the main active chemical compounds found in marijuana. CBD doesn’t make people high, isn’t intoxicating or addictive, and is gaining widespread acceptance as a natural and effective … Continue reading “ChineseInvestors.com, Inc. (CIIX) Set to Capitalize on Meteoric Growth of CBD Market”
ChineseInvestors.com, Inc. (OTCQB: CIIX) is raising funds in a series of offerings, equity sales and a private placement to meet its liquidity needs, even as it reported a 95% gain in its year-over-year operating revenues for the three months ended February 28, 2017. It has begun a private placement of a new series of its … Continue reading “ChineseInvestors.com, Inc. (CIIX) Raises Funds through a Private Placement, Sales of Equities, and Preferred Stock Offerings”
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning offered investors an update on its financial and business achievements for the fiscal third quarter ended February 28, 2017, as well as its outlook for the remainder of the current fiscal year and 2018. Among the highlights, the company reported significantly higher revenues for both the … Continue reading “NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Reports 95% YOY Revenue Growth for Quarter Ended February 28, 2017”
In China, there are close to 10 million epilepsy patients, the Chinese Overseas Medical Advisory Service Center estimates. There is no cure in the country, although risky surgery is sometimes performed in the U.S., where there are over three million people living with epilepsy. Many patients rely on Chinese herbs for temporary control. However, ChineseInvestors.com’s … Continue reading “Epilepsy Patients are the New Focus of ChineseInvestors.com, Inc.’s (CIIX) CBD Health Products”
ChineseInvestors.com, Inc. (OTCQB: CIIX) attended the ‘Invest 2017’ exhibition in Stuttgart, Germany, on April 7-8, 2017, anticipating that the conference would be an opportunity for CIIX to introduce its hemp companies and products to German investors, but CIIX is not alone in seeing the growth opportunities for medical cannabis in that market. CIIX operates a … Continue reading “ChineseInvestors.com, Inc. (CIIX) Eyes Germany’s Growing Medical Hemp Market”
